Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

First-line Advanced NSCLC Patients × CP protocol × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 14 Lung Neoplasms 3 NSCLC 2 Unresectable Stage III NSCLC 1 Non-Small Cell Lung Cancer With HER2- Mutations 1 Non Small Cell Lung Carcinoma NSCLC 1 Neoplasms 1 Neoplasm Metastasis 1 First-line Advanced NSCLC Patients 1 Carcinoma 1

Interventions

Pemetrexed 1 Immune Checkpoint Inhibitors 1 Drug Therapy 1 Carboplatin 1 CP protocol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07171606 2025-12-18

A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients

Shenyang Sunshine Pharmaceutical Co., LTD.

Phase 2 Recruiting

First-line Advanced NSCLC Patients

Data powered by HemOnc (CC BY 4.0) Colophon ⚡